Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NutriBand (NTRB) Capital Expenditures (2021 - 2025)

NutriBand (NTRB) has disclosed Capital Expenditures for 5 consecutive years, with $5324.0 as the latest value for Q2 2025.

  • For Q2 2025, Capital Expenditures fell 14.06% year-over-year to $5324.0; the TTM value through Jan 2026 reached $5324.0, down 94.22%, while the annual FY2026 figure was $5324.0, 94.22% down from the prior year.
  • Capital Expenditures hit $5324.0 in Q2 2025 for NutriBand, down from $46958.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $49137.0 in Q1 2024 and bottomed at $1272.0 in Q4 2022.
  • Average Capital Expenditures over 5 years is $22144.8, with a median of $17411.5 recorded in 2021.
  • Year-over-year, Capital Expenditures plummeted 94.01% in 2023 and then skyrocketed 390.24% in 2024.
  • NutriBand's Capital Expenditures stood at $1992.0 in 2021, then crashed by 36.14% to $1272.0 in 2022, then surged by 106.29% to $2624.0 in 2023, then skyrocketed by 1689.56% to $46958.0 in 2024, then plummeted by 88.66% to $5324.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $5324.0, $46958.0, and $38890.0 for Q2 2025, Q4 2024, and Q3 2024 respectively.